Literature DB >> 24969324

FRK inhibits migration and invasion of human glioma cells by promoting N-cadherin/β-catenin complex formation.

Qiong Shi1,2, Xu Song3, Jun Wang3, Jia Gu1,2, Weijian Zhang3, Jinxia Hu1,2, Xiuping Zhou4,5, Rutong Yu6,7.   

Abstract

Fyn-related kinase (FRK), a member of Src-related tyrosine kinases, is recently reported to function as a potent tumor suppressor in several cancer types. Our previous study has also shown that FRK over-expression inhibited the migration and invasion of glioma cells. However, the mechanism of FRK effect on glioma cell migration and invasion, a feature of human malignant gliomas, is still not clear. In this study, we found that FRK over-expression increased the protein level of N-cadherin, but not E-cadherin. Meanwhile, FRK over-expression promoted β-catenin translocation to the plasma membrane, where it formed complex with N-cadherin, while decreased β-catenin level in the nuclear fraction. In addition, down-regulation of N-cadherin by siRNA promoted the migration and invasion of glioma U251 and U87 cells and abolished the inhibitory effect of FRK on glioma cell migration and invasion. In summary, these results indicate that FRK inhibits migration and invasion of human glioma cells by promoting N-cadherin/β-catenin complex formation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24969324     DOI: 10.1007/s12031-014-0355-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  40 in total

1.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

2.  Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation.

Authors:  Noriko Hosoya; Ying Qiao; Akira Hangaishi; Lili Wang; Yasuhito Nannya; Masashi Sanada; Mineo Kurokawa; Shigeru Chiba; Hisamaru Hirai; Seishi Ogawa
Journal:  Genes Chromosomes Cancer       Date:  2005-03       Impact factor: 5.006

3.  EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin.

Authors:  Anne Rappl; Guido Piontek; Jürgen Schlegel
Journal:  J Cell Sci       Date:  2008-11-25       Impact factor: 5.285

Review 4.  Connexins, gap junctions and tissue invasion.

Authors:  Norah Defamie; Amandine Chepied; Marc Mesnil
Journal:  FEBS Lett       Date:  2014-01-20       Impact factor: 4.124

Review 5.  The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules.

Authors:  G B Grunwald
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

6.  Expression of β-catenin and E- and N-cadherin in human brainstem gliomas and clinicopathological correlations.

Authors:  Wenhao Wu; Yongji Tian; Hong Wan; Junyan Ma; Yongmei Song; Yu Wang; Liwei Zhang
Journal:  Int J Neurosci       Date:  2013-02-04       Impact factor: 2.292

7.  N-cadherin expression level as a critical indicator of invasion in non-epithelial tumors.

Authors:  Florent Péglion; Sandrine Etienne-Manneville
Journal:  Cell Adh Migr       Date:  2012-07-01       Impact factor: 3.405

Review 8.  Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression.

Authors:  Georgia Agiostratidou; James Hulit; Greg R Phillips; Rachel B Hazan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-09       Impact factor: 2.673

9.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function.

Authors:  Eun-Kyoung Yim; Guang Peng; Hui Dai; Ruozhen Hu; Kaiyi Li; Yiling Lu; Gordon B Mills; Funda Meric-Bernstam; Bryan T Hennessy; Rolf J Craven; Shiaw-Yih Lin
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

10.  Invasive behaviour of glioblastoma cell lines is associated with altered organisation of the cadherin-catenin adhesion system.

Authors:  Carla Perego; Cristina Vanoni; Silvia Massari; Andrea Raimondi; Sandra Pola; Maria Grazia Cattaneo; Maura Francolini; Lucia Maria Vicentini; Grazia Pietrini
Journal:  J Cell Sci       Date:  2002-08-15       Impact factor: 5.285

View more
  11 in total

1.  Genome-wide haplotype association study identifies BLM as a risk gene for prostate cancer in Chinese population.

Authors:  Qun Wang; Hongchao Lv; Wenhua Lv; Miao Shi; Mingming Zhang; Meiwei Luan; Hongjie Zhu; Ruijie Zhang; Yongshuai Jiang
Journal:  Tumour Biol       Date:  2014-12-04

2.  MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression.

Authors:  Giuseppina Catanzaro; Zein Mersini Besharat; Andrea Carai; Natalie Jäger; Elena Splendiani; Carole Colin; Agnese Po; Martina Chiacchiarini; Anna Citarella; Francesca Gianno; Antonella Cacchione; Evelina Miele; Francesca Diomedi Camassei; Marco Gessi; Luca Massimi; Franco Locatelli; David T W Jones; Dominique Figarella-Branger; Stefan M Pfister; Angela Mastronuzzi; Felice Giangaspero; Elisabetta Ferretti
Journal:  Biomark Res       Date:  2022-06-17

3.  Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.

Authors:  Xiuping Zhou; Shao Xie; Shishuang Wu; Yanhua Qi; Zhaohao Wang; Hao Zhang; Dong Lu; Xu Wang; Yu Dong; Guanzheng Liu; Dongxu Yang; Qiong Shi; Wenbin Bian; Rutong Yu
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

4.  Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal Axis.

Authors:  Yanqiong Zhang; Chen Yan; Yuting Li; Xia Mao; Weiwei Tao; Yuping Tang; Ya Lin; Qiuyan Guo; Jingao Duan; Na Lin
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

5.  Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation.

Authors:  Edward T Bagu; Sayem Miah; Chenlu Dai; Travis Spriggs; Yetunde Ogunbolude; Erika Beaton; Michelle Sanders; Raghuveera K Goel; Keith Bonham; Kiven E Lukong
Journal:  Oncotarget       Date:  2017-02-14

6.  Amyloid β precursor protein silencing attenuates epithelial‑mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway.

Authors:  Jin Xu; Yin Ying; Gaoyun Xiong; Liqin Lai; Qingliang Wang; Yue Yang
Journal:  Mol Med Rep       Date:  2019-05-24       Impact factor: 2.952

Review 7.  Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia.

Authors:  Justin F Creeden; Khaled Alganem; Ali S Imami; Nicholas D Henkel; F Charles Brunicardi; Shi-He Liu; Rammohan Shukla; Tushar Tomar; Faris Naji; Robert E McCullumsmith
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

8.  FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition.

Authors:  Yetunde Ogunbolude; Chenlu Dai; Edward T Bagu; Raghuveera Kumar Goel; Sayem Miah; Joshua MacAusland-Berg; Chi Ying Ng; Rajni Chibbar; Scott Napper; Leda Raptis; Frederick Vizeacoumar; Franco Vizeacoumar; Keith Bonham; Kiven Erique Lukong
Journal:  Oncotarget       Date:  2017-12-06

9.  The role of Rak in the regulation of stability and function of BRCA1.

Authors:  Jung-Lye Kim; Geun-Hyoung Ha; Loredana Campo; Mitchell F Denning; Tarun B Patel; Clodia Osipo; Shiaw-Yih Lin; Eun-Kyoung Breuer
Journal:  Oncotarget       Date:  2015-10-14

10.  TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.

Authors:  Yuta Yamada; Naoki Kimura; Ken-Ichi Takayama; Yusuke Sato; Takashi Suzuki; Kotaro Azuma; Tetsuya Fujimura; Kazuhiro Ikeda; Haruki Kume; Satoshi Inoue
Journal:  Cancer Sci       Date:  2020-01-20       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.